GlaxoSmithKline (two travel vaccines) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

GlaxoSmithKline (two travel vaccines) General Information

Description

Manufacturing and global rights to Rabipur/RabAvert and Encepur in Brentford, United Kingdom. The vaccines provide pre- and post-exposure protection against rabies and European (Western) tick-borne encephalitis (TBE) virus.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Brentford
  • England, United Kingdom
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Acquirer
Bavarian Nordic
Corporate Office
  • Brentford
  • England, United Kingdom

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GlaxoSmithKline (two travel vaccines) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore GlaxoSmithKline (two travel vaccines)‘s full profile, request access.

Request a free trial

GlaxoSmithKline (two travel vaccines) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore GlaxoSmithKline (two travel vaccines)‘s full profile, request access.

Request a free trial

GlaxoSmithKline (two travel vaccines) FAQs

  • Where is GlaxoSmithKline (two travel vaccines) headquartered?

    GlaxoSmithKline (two travel vaccines) is headquartered in Brentford, United Kingdom.

  • What industry is GlaxoSmithKline (two travel vaccines) in?

    GlaxoSmithKline (two travel vaccines)’s primary industry is Buildings and Property.

  • Is GlaxoSmithKline (two travel vaccines) a private or public company?

    GlaxoSmithKline (two travel vaccines) is a Private company.

  • What is the current valuation of GlaxoSmithKline (two travel vaccines)?

    The current valuation of GlaxoSmithKline (two travel vaccines) is .

  • What is GlaxoSmithKline (two travel vaccines)’s current revenue?

    The current revenue for GlaxoSmithKline (two travel vaccines) is .

  • Who are GlaxoSmithKline (two travel vaccines)’s investors?

    GSK has invested in GlaxoSmithKline (two travel vaccines).

  • When was GlaxoSmithKline (two travel vaccines) acquired?

    GlaxoSmithKline (two travel vaccines) was acquired on 31-Dec-2019.

  • Who acquired GlaxoSmithKline (two travel vaccines)?

    GlaxoSmithKline (two travel vaccines) was acquired by Bavarian Nordic.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »